Menu Search
Equities

AroCell AB (publ)

80R:FRA

AroCell AB (publ)

Actions
  • Price (EUR)0.02
  • Today's Change-0.003 / -13.79%
  • Shares traded0.00
  • 1 Year change-57.98%
  • Beta--
Data delayed at least 15 minutes, as of Apr 19 2024 07:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

AroCell publ AB is a Sweden-based diagnostic Company engaged in the development of markers for determination of cell growth (TK 210) and apoptosis. The Company's principal product candidate, TK-immuno/hem, is a test for monitoring and follow up of blood cancer. The test is based on a patented technology, which have already been evaluated in an early product prototype ELISA method. Apart from that, the Company develops a marker for solid tumor cancer disease. The AroCell cooperates with partners within development, production and sales.

  • Revenue in SEK (TTM)43.04m
  • Net income in SEK-59.30m
  • Incorporated2000
  • Employees--
  • Location
    AroCell AB (publ)Karlsbodavagen 39BROMMA 168 67SwedenSWE
  • Phone+46 18503020
  • Websitehttps://arocell.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.